LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2019. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $257,000 | -24.6% | 80,615 | +0.7% | 0.00% | – |
Q1 2022 | $341,000 | -3.4% | 80,053 | +5.3% | 0.00% | – |
Q4 2021 | $353,000 | +13.5% | 76,006 | -2.4% | 0.00% | – |
Q3 2021 | $311,000 | -2.2% | 77,839 | +4.7% | 0.00% | – |
Q2 2021 | $318,000 | -67.1% | 74,312 | -67.4% | 0.00% | – |
Q1 2021 | $967,000 | -0.5% | 228,088 | -8.9% | 0.00% | – |
Q4 2020 | $972,000 | -12.0% | 250,427 | -8.6% | 0.00% | – |
Q3 2020 | $1,104,000 | -19.5% | 273,948 | -14.9% | 0.00% | – |
Q2 2020 | $1,371,000 | +9.5% | 321,968 | +7.9% | 0.00% | – |
Q1 2020 | $1,252,000 | +6.9% | 298,285 | +0.1% | 0.00% | – |
Q4 2019 | $1,171,000 | -55.6% | 298,063 | -0.6% | 0.00% | -100.0% |
Q3 2019 | $2,639,000 | +3.3% | 299,889 | +8.6% | 0.00% | 0.0% |
Q2 2019 | $2,555,000 | +44.8% | 276,154 | +0.7% | 0.00% | – |
Q1 2019 | $1,764,000 | -37.2% | 274,274 | -7.9% | 0.00% | -100.0% |
Q4 2018 | $2,809,000 | -54.1% | 297,893 | -2.1% | 0.00% | 0.0% |
Q3 2018 | $6,125,000 | -29.8% | 304,226 | +1.8% | 0.00% | -50.0% |
Q2 2018 | $8,719,000 | +16.9% | 298,883 | +19.3% | 0.00% | 0.0% |
Q1 2018 | $7,459,000 | -7.7% | 250,501 | -0.3% | 0.00% | 0.0% |
Q4 2017 | $8,084,000 | -7.7% | 251,193 | -0.3% | 0.00% | 0.0% |
Q3 2017 | $8,758,000 | +14.6% | 251,844 | -1.9% | 0.00% | 0.0% |
Q2 2017 | $7,641,000 | +26.1% | 256,640 | +26.4% | 0.00% | 0.0% |
Q1 2017 | $6,058,000 | +75.1% | 202,962 | +2.8% | 0.00% | +100.0% |
Q4 2016 | $3,460,000 | -22.2% | 197,420 | +5.6% | 0.00% | 0.0% |
Q3 2016 | $4,447,000 | +46.6% | 186,972 | -1.4% | 0.00% | 0.0% |
Q2 2016 | $3,034,000 | -14.8% | 189,583 | +11.3% | 0.00% | 0.0% |
Q1 2016 | $3,562,000 | -21.2% | 170,290 | +1.7% | 0.00% | 0.0% |
Q4 2015 | $4,520,000 | +15.2% | 167,408 | +18.5% | 0.00% | 0.0% |
Q3 2015 | $3,925,000 | +292.9% | 141,219 | +246.4% | 0.00% | – |
Q2 2015 | $999,000 | +146.7% | 40,769 | +84.3% | 0.00% | – |
Q1 2015 | $405,000 | +34.6% | 22,125 | +35.5% | 0.00% | – |
Q4 2014 | $301,000 | +110.5% | 16,325 | +9.5% | 0.00% | – |
Q3 2014 | $143,000 | – | 14,913 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |